Monthly Archives: September 2020

//September

LUTATHERA® Funded in Nova Scotia

As of August 1, 2020, patients with midgut, GEP-NETs will now be eligible for treatment with LUTATHERA® [lutetium (177Lu) oxodotreotide]. This listing covers adult patients with somatostatin receptor-positive (SSR+) midgut [...]

By | 2020-09-06T16:03:58+00:00 September 4th, 2020|Treatment News|Comments Off on LUTATHERA® Funded in Nova Scotia